FDA Inspection 1168201 — Wyeth Pharmaceutical Division Of Wyeth Holdings LLC

Wyeth Pharmaceutical Division Of Wyeth Holdings LLC — FEI 2410662

The FDA completed an inspection of Wyeth Pharmaceutical Division Of Wyeth Holdings LLC on Apr 13, 2022 in Pearl River, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 13, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pearl River, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.